1. bookVolume 23 (2015): Issue 2 (June 2015)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Thirty years in hemostasis research in Cluj Napoca

Published Online: 23 Jun 2015
Page range: 245 - 246
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English

1. Brudaşcă I, Cucuianu M. Pathogenic role of abnormal fatty acids and adipokines in the portal flow. Relevance for metabolic syndrome, hepatic steatosis and steatohepatitis. Rom J Intern Med. 2007;45(2):149-57.Search in Google Scholar

2. Cucuianu M, Brudaşcă I. Coagulation factor XIII, impaired fibrinolysis and cardiovascular disease. Rev Romana Med Lab. 2011;19(2):119-27.Search in Google Scholar

3. Brudaşcă I, Cucuianu M. Anticoagulant mechanisms are modulated by vascular endothelial cells. Rev Romana Med Lab. 2010;18(3):7-14.Search in Google Scholar

4. Cucuianu M, Brudașcă I, Pleșca L, Bodizs G, Colhon D, Cucuianu A. Reciprocal antagonism between inflammation and the protein C system. Rev Romana Med Lab. 2013;21(2):129-33. DOI: 10.2478/rrlm-2013-000310.2478/rrlm-2013-0003Search in Google Scholar

5. Karnsakul W, Gillespie S, Skitarelic K, Hummel M. Obesity and Reversed Growth Retardation in a Child with Type Ia Glycogen Storage Disease. J Pediatric Endocrinol and Metabolism. 2010;23(5):507-12. DOI: 10.1515/jpem.2010.08310.1515/jpem.2010.083Search in Google Scholar

6. Mikstowicz V, Lucero D, Zago V, Cacciagiu L, Lopez G, Gonzalez E, et al. Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance. Diabetes Metab Res Rev. 2012;28(6):535-41 DOI: 10.1002/dmrr.231210.1002/dmrr.2312Search in Google Scholar

7. MacKenzie JA, Roosa KA, Gump BB, Dumas AK, Bendinskas KG. Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children. Appl Physiol Nutr Metab. 2010;35(4):518-25. DOI: 10.1139/H10-03910.1139/H10-039Search in Google Scholar

8. Cucuianu M, Missits I, Olinic N, Roman S. Increased ristocetin-cofactor in acute myocardial infarction. Thromb Haemost. 1980;43:41-4.10.1055/s-0038-1650008Search in Google Scholar

9. Schorer AE, Moldow CF, Rick ME. Interleukin 1 or endotoxin increase the release of von Willebrand factor from human endothelial cells. Brit J Haematol. 1987;67:192-7. DOI: 10.1111/j.1365-2141.1987. tb02326.xSearch in Google Scholar

10. Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD. von Willebrand factor is an acute phase reactant in man. Thromb Res. 1989;53(4):387-94. DOI: 10.1016/0049-3848(89)90317-410.1016/0049-3848(89)90317-4Search in Google Scholar

11. Trif I, Pop E, Cucuianu M, Belciug L. Thrombastenia Glanzmann. Clujul medical. 1991;64:49-54.Search in Google Scholar

12. Cucuianu M, Crâsnic, Knauer O, Roman S. Severe bleeding in α2plasmin inhibitor deficiency. Rev Roum Biochim. 1989;26:273-7.Search in Google Scholar

13. Cucuianu M, Comes L, Roman S, Boeru A. Antithrombin deficiency in a Romanian family. Pathogenic role of concomitently increased plasma level of clotting factors VII and X. Rev Roum Med Int. 1984;22:13-17.Search in Google Scholar

14. Cucuianu M, Hagău N, Cotul S, Cardan E, Giurgea I. Heterozyhgous protein C deficiency and coumarin necrosis of the skin. Rom Journ Int Med. 1992;30(2):105-11.Search in Google Scholar

15. Seyfarth HJ, Siegemund A, Helling L, Woinke M, Pfeiffer D, Rühlmann C. Recurrent coumarin necrosis in type II protein S deficiency. Vasa. 2001;30(1):72-5. DOI: 10.1024/0301-1526.30.1.7210.1024/0301-1526.30.1.7211284095Search in Google Scholar

16. Cucuianu M, Trif I, Cucuianu A. Hemostaza - Biochimie, fiziopatologie, clinică. Editura Dacia Cluj Napoca, 1994.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo